US OptionsDetailed Quotes

VERV250516P15000

Watchlist

6.90
0.000.00%

15min DelayClose May 9 16:00 ET

0.00High0.00Low

Verve Therapeutics Stock Discussion

LuckyLuke

Apr 16 02:05

$Verve Therapeutics (VERV.US)$ probably will run up after hours imo

72055196

Apr 15 21:38

$Verve Therapeutics (VERV.US)$ @This_Guy

Stock_Drift

Apr 15 18:45

Pre Market Ticks. 6:44am 4/15

$Femto Technologies (FMTO.US)$ $Baijiayun (RTC.US)$ $Verve Therapeutics (VERV.US)$ $EB ENVIRONMENT (00257.HK)$ $Gamehaus Holdings (GMHS.US)$ $USA Rare Earth (USAR.US)$ $Office Properties Income Trust (OPI.US)$ $Rail Vision (RVSN.US)$ $CISO Global (CISO.US)$ $Healthcare Triangle (HCTI.US)$ $NLS Pharmaceutics (NLSP.US)$ $ARB IOT Group (ARBB.US)$ $Splash Beverage (SBEV.US)$ $Synergy CHC (SNYR.US)$
📊⚡️📊

Trytosaveabit

Apr 15 03:19

$Verve Therapeutics (VERV.US)$ Nice recovery

Tinz

Apr 14 21:11

Earnings Call 5/8 a bit soon ehh
Over sold on opening wow

Tonyco

Apr 14 20:37

$Verve Therapeutics (VERV.US)$

Teddy123

Apr 14 20:30

Verve Therapeutics Announces Positive Initial Data from the Heart-2 Phase 1b Clinical Trial of VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9

$Verve Therapeutics (VERV.US)$
Breakthrough: New Gene Editing Drug Cuts Bad Cholesterol by 53% in Heart Disease Patients

Tinz

Apr 14 20:14

$Verve Therapeutics (VERV.US)$ what do you all think of this ? Almost oversold....

Trytosaveabit

Apr 14 19:55

$Verve Therapeutics (VERV.US)$ Nice lil low volume climb

Trytosaveabit

Apr 14 19:13

update

$Verve Therapeutics (VERV.US)$ Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced positive initial data from the Heart-2 Phase 1b clinical trial of VERVE-102. The Heart-2 Phase 1b clinical trial is evaluating patients with heterozygous familial hypercholesterolemia (HeFH) and/or premature coronary artery disease (CAD), two populations that require deep and durable reductions of low-density lipoprotein choleste...

No comment yet